Fidelity Investments’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.11M | Sell |
150,730
-11,719
| -7% | -$164K | ﹤0.01% | 2471 |
|
|
2025
Q1 | $2.54M | Sell |
162,449
-22,110
| -12% | -$346K | ﹤0.01% | 2370 |
|
|
2024
Q4 | $2.57M | Buy |
184,559
+13,340
| +8% | +$186K | ﹤0.01% | 2361 |
|
|
2024
Q3 | $1.59M | Buy |
171,219
+34,884
| +26% | +$324K | ﹤0.01% | 2463 |
|
|
2024
Q2 | $1.27M | Sell |
136,335
-4,763
| -3% | -$44.3K | ﹤0.01% | 2458 |
|
|
2024
Q1 | $1.4M | Sell |
141,098
-1,081,306
| -88% | -$10.7M | ﹤0.01% | 2420 |
|
|
2023
Q4 | $3.95M | Sell |
1,222,404
-7,039,638
| -85% | -$22.7M | ﹤0.01% | 2123 |
|
|
2023
Q3 | $43.9M | Sell |
8,262,042
-950,744
| -10% | -$5.05M | ﹤0.01% | 1295 |
|
|
2023
Q2 | $87.8M | Buy |
9,212,786
+50,356
| +0.5% | +$480K | 0.01% | 1055 |
|
|
2023
Q1 | $101M | Buy |
9,162,430
+23,257
| +0.3% | +$256K | 0.01% | 985 |
|
|
2022
Q4 | $135M | Buy |
9,139,173
+209,942
| +2% | +$3.11M | 0.01% | 848 |
|
|
2022
Q3 | $171M | Buy |
8,929,231
+1,216,551
| +16% | +$23.2M | 0.02% | 734 |
|
|
2022
Q2 | $164M | Buy |
7,712,680
+155,087
| +2% | +$3.3M | 0.02% | 771 |
|
|
2022
Q1 | $146M | Buy |
7,557,593
+13,381
| +0.2% | +$258K | 0.01% | 910 |
|
|
2021
Q4 | $156M | Buy |
7,544,212
+7,947
| +0.1% | +$165K | 0.01% | 894 |
|
|
2021
Q3 | $180M | Buy |
7,536,265
+5,525
| +0.1% | +$132K | 0.01% | 852 |
|
|
2021
Q2 | $206M | Sell |
7,530,740
-105,709
| -1% | -$2.88M | 0.02% | 819 |
|
|
2021
Q1 | $221M | Buy |
7,636,449
+1,091,285
| +17% | +$31.6M | 0.02% | 747 |
|
|
2020
Q4 | $184M | Buy |
6,545,164
+816,771
| +14% | +$23M | 0.02% | 780 |
|
|
2020
Q3 | $168M | Buy |
5,728,393
+5,211
| +0.1% | +$153K | 0.02% | 699 |
|
|
2020
Q2 | $173M | Buy |
5,723,182
+9,839
| +0.2% | +$298K | 0.02% | 662 |
|
|
2020
Q1 | $170M | Buy |
+5,713,343
| New | +$170M | 0.02% | 558 |
|